The Brain and Mind Centre (BMC) Neurogenetics and Epigenetics research group is harnessing the rapid development of sequencing technology, bioinformatics and cellular models to identify novel neurodegenerative genes in frontotemporal dementia, Parkinson’s disease and Alzheimer’s disease and to understand their underlying pathogenic mechanisms. These discoveries will lead to the development novel biomarkers that inform on underlying disease, novel therapeutics, and to improve health outcomes for patients undergoing genetic screening.